
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (22): 2798-2805.DOI: 10.12114/j.issn.1007-9572.2025.0009
Special Issue: 心血管最新文章合辑
• Original Research·Focus on Body Index and Health Relationship • Previous Articles Next Articles
Received:2025-03-03
Revised:2025-04-17
Published:2025-08-05
Online:2025-06-30
Contact:
WANG Weiqiang
通讯作者:
王为强
作者简介:作者贡献:
杨菲提出主要研究目标,负责研究的构思与设计,开展研究,撰写论文;杨菲、韩正进行数据收集与整理、统计学处理、图表绘制;付晓雅、顾瀚东、顾可羿进行论文修订;王为强负责文章的质量控制与审查,对文章整体负责,监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2025.0009
| 变量 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| 非CMM组(n=14 546) | CMM组(n=2 741) | Z(χ2)值 | P值 | 非CMM组(n=20 901) | CMM组(n=4 249) | Z(χ2)值 | P值 | |
| 年龄[M(P25,P75),岁] | 62(52,68) | 64(55,69) | -12.306a | <0.001 | 54(48,64) | 63(55,68) | -37.118a | <0.001 |
| 学历高中及以上[例(%)] | 1 472(10.1) | 417(15.2) | 61.484a | <0.001 | 1 991(9.5) | 318(7.5) | 17.655a | <0.001 |
| 吸烟[例(%)] | 7 334(50.4) | 1 250(45.6) | 21.395a | <0.001 | 360(1.7) | 83(2.0) | 1.089a | 0.297 |
| 饮酒[例(%)] | 4 845(33.3) | 871(31.8) | 2.444a | 0.118 | 744(3.6) | 147(3.5) | 0.103a | 0.784 |
| BMI[M(P25,P75),kg/m2)] | 22.11(20.83,23.11) | 22.60(21.50,23.38) | -14.143 | <0.001 | 22.10(20.93,23.05) | 22.51(21.40,23.31) | -14.160 | <0.001 |
| TC[M(P25,P75),mmol/L)] | 4.30(3.75,4.88) | 4.36(3.66,5.29) | -5.452 | <0.001 | 4.62(4.03,5.23) | 5.18(4.33,6.27) | -30.494 | <0.001 |
| HDL-C[M(P25,P75),mmol/L)] | 1.52(1.27,1.83) | 1.30(1.01,1.64) | -24.995 | <0.001 | 1.61(1.36,1.9) | 1.48(1.21,1.80) | -18.077 | <0.001 |
| TG[M(P25,P75),mmol/L)] | 1.04(0.82,1.39) | 1.46(1.02,2.37) | -32.020 | <0.001 | 1.18(0.92,1.58) | 1.88(1.27,2.63) | -50.149 | <0.001 |
| LDL-C[M(P25,P75),mmol/L)] | 2.15(1.69,2.65) | 2.20(1.64,2.94) | -5.286 | <0.001 | 2.33(1.85,2.87) | 2.70(1.98,3.59) | -22.955 | <0.001 |
| RC[M(P25,P75),mmol/L)] | 0.48(0.37,0.65) | 0.66(0.46,1.08) | -28.120 | <0.001 | 0.54(0.41,0.75) | 0.85(0.57,1.21) | -44.765 | <0.001 |
| FPG[M(P25,P75),mmol/L)] | 5.7(5.1,6.2) | 6.2(5.6,7.6) | -27.951 | <0.001 | 5.6(5.1,6.2) | 6.3(5.5,7.6) | -36.400 | <0.001 |
| TyG指数[M(P25,P75)] | 8.47(8.20,8.78) | 8.99(8.56,9.44) | -41.121 | <0.001 | 8.59(8.30,8.89) | 9.20(8.80,9.55) | -60.059 | <0.001 |
| BRI[M(P25,P75)] | 3.01(2.55,3.45) | 3.28(2.85,3.75) | -20.191 | <0.001 | 3.24(2.73,3.73) | 3.55(3.08,4.10) | -26.200 | <0.001 |
| 收缩压[M(P25,P75),mmHg)] | 130.5(121.0,142.0) | 144.5(134.0,157.5) | -35.507 | <0.001 | 127.5(117.0,139.0) | 147.0(136.5,160.0) | -56.373 | <0.001 |
| 舒张压[M(P25,P75),mmHg)] | 78.5(72.5,85.0) | 84.5(77.5,91.5) | -26.349 | <0.001 | 75.5(69.5,82.0) | 81.0(74.5,89.0) | -32.876 | <0.001 |
| 高血压[例(%)] | 5 315(36.5) | 2 555(93.2) | 2 987.215a | <0.001 | 6 237(29.8) | 3 958(93.2) | 5 871.806a | <0.001 |
| 糖尿病[例(%)] | 285(2.0) | 919(33.5) | 3 547.232a | <0.001 | 439(2.1) | 1 487(35.0) | 5 403.648a | <0.001 |
| 血脂异常[例(%)] | 1 423(9.8) | 1 897(69.2) | 5 249.012a | <0.001 | 2 476(11.8) | 3 247(76.4) | 8 376.183a | <0.001 |
| 心脏病[例(%)] | 40(0.3) | 116(4.2) | 403.837a | <0.001 | 44(0.2) | 118(2.8) | 363.466a | <0.001 |
| 脑卒中[例(%)] | 105(0.7) | 547(20.0) | 2 351.028a | <0.001 | 81(0.4) | 544(12.8) | 2 246.100a | <0.001 |
Table 1 Demographics,biochemical parameters,and disease history between the CMM group and non-CMM groups in males and females
| 变量 | 男 | 女 | ||||||
|---|---|---|---|---|---|---|---|---|
| 非CMM组(n=14 546) | CMM组(n=2 741) | Z(χ2)值 | P值 | 非CMM组(n=20 901) | CMM组(n=4 249) | Z(χ2)值 | P值 | |
| 年龄[M(P25,P75),岁] | 62(52,68) | 64(55,69) | -12.306a | <0.001 | 54(48,64) | 63(55,68) | -37.118a | <0.001 |
| 学历高中及以上[例(%)] | 1 472(10.1) | 417(15.2) | 61.484a | <0.001 | 1 991(9.5) | 318(7.5) | 17.655a | <0.001 |
| 吸烟[例(%)] | 7 334(50.4) | 1 250(45.6) | 21.395a | <0.001 | 360(1.7) | 83(2.0) | 1.089a | 0.297 |
| 饮酒[例(%)] | 4 845(33.3) | 871(31.8) | 2.444a | 0.118 | 744(3.6) | 147(3.5) | 0.103a | 0.784 |
| BMI[M(P25,P75),kg/m2)] | 22.11(20.83,23.11) | 22.60(21.50,23.38) | -14.143 | <0.001 | 22.10(20.93,23.05) | 22.51(21.40,23.31) | -14.160 | <0.001 |
| TC[M(P25,P75),mmol/L)] | 4.30(3.75,4.88) | 4.36(3.66,5.29) | -5.452 | <0.001 | 4.62(4.03,5.23) | 5.18(4.33,6.27) | -30.494 | <0.001 |
| HDL-C[M(P25,P75),mmol/L)] | 1.52(1.27,1.83) | 1.30(1.01,1.64) | -24.995 | <0.001 | 1.61(1.36,1.9) | 1.48(1.21,1.80) | -18.077 | <0.001 |
| TG[M(P25,P75),mmol/L)] | 1.04(0.82,1.39) | 1.46(1.02,2.37) | -32.020 | <0.001 | 1.18(0.92,1.58) | 1.88(1.27,2.63) | -50.149 | <0.001 |
| LDL-C[M(P25,P75),mmol/L)] | 2.15(1.69,2.65) | 2.20(1.64,2.94) | -5.286 | <0.001 | 2.33(1.85,2.87) | 2.70(1.98,3.59) | -22.955 | <0.001 |
| RC[M(P25,P75),mmol/L)] | 0.48(0.37,0.65) | 0.66(0.46,1.08) | -28.120 | <0.001 | 0.54(0.41,0.75) | 0.85(0.57,1.21) | -44.765 | <0.001 |
| FPG[M(P25,P75),mmol/L)] | 5.7(5.1,6.2) | 6.2(5.6,7.6) | -27.951 | <0.001 | 5.6(5.1,6.2) | 6.3(5.5,7.6) | -36.400 | <0.001 |
| TyG指数[M(P25,P75)] | 8.47(8.20,8.78) | 8.99(8.56,9.44) | -41.121 | <0.001 | 8.59(8.30,8.89) | 9.20(8.80,9.55) | -60.059 | <0.001 |
| BRI[M(P25,P75)] | 3.01(2.55,3.45) | 3.28(2.85,3.75) | -20.191 | <0.001 | 3.24(2.73,3.73) | 3.55(3.08,4.10) | -26.200 | <0.001 |
| 收缩压[M(P25,P75),mmHg)] | 130.5(121.0,142.0) | 144.5(134.0,157.5) | -35.507 | <0.001 | 127.5(117.0,139.0) | 147.0(136.5,160.0) | -56.373 | <0.001 |
| 舒张压[M(P25,P75),mmHg)] | 78.5(72.5,85.0) | 84.5(77.5,91.5) | -26.349 | <0.001 | 75.5(69.5,82.0) | 81.0(74.5,89.0) | -32.876 | <0.001 |
| 高血压[例(%)] | 5 315(36.5) | 2 555(93.2) | 2 987.215a | <0.001 | 6 237(29.8) | 3 958(93.2) | 5 871.806a | <0.001 |
| 糖尿病[例(%)] | 285(2.0) | 919(33.5) | 3 547.232a | <0.001 | 439(2.1) | 1 487(35.0) | 5 403.648a | <0.001 |
| 血脂异常[例(%)] | 1 423(9.8) | 1 897(69.2) | 5 249.012a | <0.001 | 2 476(11.8) | 3 247(76.4) | 8 376.183a | <0.001 |
| 心脏病[例(%)] | 40(0.3) | 116(4.2) | 403.837a | <0.001 | 44(0.2) | 118(2.8) | 363.466a | <0.001 |
| 脑卒中[例(%)] | 105(0.7) | 547(20.0) | 2 351.028a | <0.001 | 81(0.4) | 544(12.8) | 2 246.100a | <0.001 |
| 变量 | M1(n=4 290) | M2(n=4 341) | M3(n=4 329) | M4(n=4 327) | H趋势(χ2趋势)值 | P值 |
|---|---|---|---|---|---|---|
| CMM[例(%)] | 362(8.4) | 605(13.9) | 750(17.3) | 1 024(23.7) | 388.943a | <0.001 |
| 学历高中及以上[例(%)] | 422(9.8) | 503(11.6) | 516(11.9) | 448(10.4) | 0.766a | 0.381 |
| 吸烟[例(%)] | 2 274(53.0) | 2 180(50.2) | 2 107(48.7) | 2 023(46.8) | 35.531a | <0.001 |
| 饮酒[例(%)] | 1 302(30.3) | 1 476(34.0) | 1 491(34.4) | 1 447(33.4) | 9.123a | 0.003 |
| TC[M(P25,P75),mmol/L] | 4.25(3.73,4.82) | 4.32(3.75,4.92) | 4.30(3.74,4.955) | 4.34(3.75,5.01) | 28.647 | <0.001 |
| HDL-C[M(P25,P75),mmol/L] | 1.60(1.33,1.92) | 1.52(1.26,1.81) | 1.45(1.22,1.76) | 1.41(1.18,1.72) | 417.798 | <0.001 |
| TG[M(P25,P75),mmol/L] | 0.98(0.79,1.28) | 1.07(0.83,1.47) | 1.13(0.86,1.57) | 1.17(0.89,1.66) | 437.766 | <0.001 |
| LDL-C[M(P25,P75),mmol/L] | 2.08(1.63,2.55) | 2.15(1.70,2.68) | 2.17(1.70,2.72) | 2.24(1.73,2.81) | 106.718 | <0.001 |
| RC[M(P25,P75),mmol/L] | 0.45(0.36,0.60) | 0.49(0.38,0.70) | 0.52(0.39,0.75) | 0.54(0.40,0.78) | 379.595 | <0.001 |
| FPG[M(P25,P75),mmol/L] | 5.6(5.1,6.2) | 5.7(5.2,6.3) | 5.8(5.2,6.5) | 5.8(5.3,6.6) | 251.207 | <0.001 |
| TyG指数[M(P25,P75)] | 8.39(8.15,8.70) | 8.50(8.23,8.84) | 8.58(8.28,8.94) | 8.63(8.32,9.03) | 609.642 | <0.001 |
| 收缩压[M(P25,P75),mmHg] | 129.0(119.0,141.0) | 131.5(121.5,144.5) | 133.0(123.0,146.0) | 135.5(124.5,149.5) | 331.547 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 77.0(71.5,83.5) | 79.5(73.0,86.0) | 80.0(74.0,86.5) | 80.5(74.0,87.5) | 254.659 | <0.001 |
Table 2 Comparison of different characteristics of BRI quartile levels in males
| 变量 | M1(n=4 290) | M2(n=4 341) | M3(n=4 329) | M4(n=4 327) | H趋势(χ2趋势)值 | P值 |
|---|---|---|---|---|---|---|
| CMM[例(%)] | 362(8.4) | 605(13.9) | 750(17.3) | 1 024(23.7) | 388.943a | <0.001 |
| 学历高中及以上[例(%)] | 422(9.8) | 503(11.6) | 516(11.9) | 448(10.4) | 0.766a | 0.381 |
| 吸烟[例(%)] | 2 274(53.0) | 2 180(50.2) | 2 107(48.7) | 2 023(46.8) | 35.531a | <0.001 |
| 饮酒[例(%)] | 1 302(30.3) | 1 476(34.0) | 1 491(34.4) | 1 447(33.4) | 9.123a | 0.003 |
| TC[M(P25,P75),mmol/L] | 4.25(3.73,4.82) | 4.32(3.75,4.92) | 4.30(3.74,4.955) | 4.34(3.75,5.01) | 28.647 | <0.001 |
| HDL-C[M(P25,P75),mmol/L] | 1.60(1.33,1.92) | 1.52(1.26,1.81) | 1.45(1.22,1.76) | 1.41(1.18,1.72) | 417.798 | <0.001 |
| TG[M(P25,P75),mmol/L] | 0.98(0.79,1.28) | 1.07(0.83,1.47) | 1.13(0.86,1.57) | 1.17(0.89,1.66) | 437.766 | <0.001 |
| LDL-C[M(P25,P75),mmol/L] | 2.08(1.63,2.55) | 2.15(1.70,2.68) | 2.17(1.70,2.72) | 2.24(1.73,2.81) | 106.718 | <0.001 |
| RC[M(P25,P75),mmol/L] | 0.45(0.36,0.60) | 0.49(0.38,0.70) | 0.52(0.39,0.75) | 0.54(0.40,0.78) | 379.595 | <0.001 |
| FPG[M(P25,P75),mmol/L] | 5.6(5.1,6.2) | 5.7(5.2,6.3) | 5.8(5.2,6.5) | 5.8(5.3,6.6) | 251.207 | <0.001 |
| TyG指数[M(P25,P75)] | 8.39(8.15,8.70) | 8.50(8.23,8.84) | 8.58(8.28,8.94) | 8.63(8.32,9.03) | 609.642 | <0.001 |
| 收缩压[M(P25,P75),mmHg] | 129.0(119.0,141.0) | 131.5(121.5,144.5) | 133.0(123.0,146.0) | 135.5(124.5,149.5) | 331.547 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 77.0(71.5,83.5) | 79.5(73.0,86.0) | 80.0(74.0,86.5) | 80.5(74.0,87.5) | 254.659 | <0.001 |
| 变量 | F1(n=6 211) | F2(n=6 364) | F3(n=6 275) | F4(n=6 300) | H趋势(χ2趋势)值 | P值 |
|---|---|---|---|---|---|---|
| CMM[例(%)] | 574(9.2) | 884(13.9) | 1 171(18.7) | 1 620(25.7) | 655.442a | <0.001 |
| 学历高中及以上[例(%)] | 945(15.2) | 651(10.2) | 450(7.2) | 263(4.2) | 490.556a | <0.001 |
| 吸烟[例(%)] | 109(1.8) | 101(1.6) | 97(1.5) | 136(2.2) | 2.518a | 0.113 |
| 饮酒[例(%)] | 184(3.0) | 199(3.1) | 230(3.7) | 278(4.4) | 21.978a | <0.001 |
| TC[M(P25,P75),mmol/L] | 4.55(3.97,5.20) | 4.64(4.04,5.30) | 4.73(4.11,5.38) | 4.84(4.19,5.53) | 248.916 | <0.001 |
| HDL-C[M(P25,P75),mmol/L] | 1.68(1.42,1.99) | 1.59(1.33,1.88) | 1.56(1.30,1.84) | 1.53(1.29,1.83) | 402.961 | <0.001 |
| TG[M(P25,P75),mmol/L] | 1.12(0.86,1.52) | 1.22(0.94,1.67) | 1.30(0.98,1.80) | 1.37(1.03,1.90) | 662.532 | <0.001 |
| LDL-C[M(P25,P75),mmol/L] | 2.24(1.76,2.80) | 2.33(1.86,2.90) | 2.40(1.91,3.00) | 2.52(1.99,3.12) | 348.79 | <0.001 |
| RC[M(P25,P75),mmol/L] | 0.51(0.39,0.71) | 0.57(0.43,0.80) | 0.60(0.45,0.86) | 0.63(0.47,0.89) | 563.731 | <0.001 |
| FPG[M(P25,P75),mmol/L] | 5.5(5.0,6.1) | 5.6(5.1,6.3) | 5.7(5.2,6.4) | 5.9(5.3,6.7) | 611.953 | <0.001 |
| TyG指数[M(P25,P75)] | 8.52(8.24,8.85) | 8.63(8.32,8.97) | 8.72(8.40,9.07) | 8.79(8.47,9.18) | 1 012.035 | <0.001 |
| 收缩压[M(P25,P75),mmHg] | 125.0(114.0,137.5) | 128.5(117.5,142.5) | 131.0(120.5,145.5) | 136.0(124.0,151.0) | 1 142.311 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 75.0(69.0,81.5) | 76.5(70.0,83.0) | 77.0(71.0,83.5) | 77.0(71.0,84.0) | 175.16 | <0.001 |
Table 3 Comparison of different characteristics of BRI quartile levels of females
| 变量 | F1(n=6 211) | F2(n=6 364) | F3(n=6 275) | F4(n=6 300) | H趋势(χ2趋势)值 | P值 |
|---|---|---|---|---|---|---|
| CMM[例(%)] | 574(9.2) | 884(13.9) | 1 171(18.7) | 1 620(25.7) | 655.442a | <0.001 |
| 学历高中及以上[例(%)] | 945(15.2) | 651(10.2) | 450(7.2) | 263(4.2) | 490.556a | <0.001 |
| 吸烟[例(%)] | 109(1.8) | 101(1.6) | 97(1.5) | 136(2.2) | 2.518a | 0.113 |
| 饮酒[例(%)] | 184(3.0) | 199(3.1) | 230(3.7) | 278(4.4) | 21.978a | <0.001 |
| TC[M(P25,P75),mmol/L] | 4.55(3.97,5.20) | 4.64(4.04,5.30) | 4.73(4.11,5.38) | 4.84(4.19,5.53) | 248.916 | <0.001 |
| HDL-C[M(P25,P75),mmol/L] | 1.68(1.42,1.99) | 1.59(1.33,1.88) | 1.56(1.30,1.84) | 1.53(1.29,1.83) | 402.961 | <0.001 |
| TG[M(P25,P75),mmol/L] | 1.12(0.86,1.52) | 1.22(0.94,1.67) | 1.30(0.98,1.80) | 1.37(1.03,1.90) | 662.532 | <0.001 |
| LDL-C[M(P25,P75),mmol/L] | 2.24(1.76,2.80) | 2.33(1.86,2.90) | 2.40(1.91,3.00) | 2.52(1.99,3.12) | 348.79 | <0.001 |
| RC[M(P25,P75),mmol/L] | 0.51(0.39,0.71) | 0.57(0.43,0.80) | 0.60(0.45,0.86) | 0.63(0.47,0.89) | 563.731 | <0.001 |
| FPG[M(P25,P75),mmol/L] | 5.5(5.0,6.1) | 5.6(5.1,6.3) | 5.7(5.2,6.4) | 5.9(5.3,6.7) | 611.953 | <0.001 |
| TyG指数[M(P25,P75)] | 8.52(8.24,8.85) | 8.63(8.32,8.97) | 8.72(8.40,9.07) | 8.79(8.47,9.18) | 1 012.035 | <0.001 |
| 收缩压[M(P25,P75),mmHg] | 125.0(114.0,137.5) | 128.5(117.5,142.5) | 131.0(120.5,145.5) | 136.0(124.0,151.0) | 1 142.311 | <0.001 |
| 舒张压[M(P25,P75),mmHg] | 75.0(69.0,81.5) | 76.5(70.0,83.0) | 77.0(71.0,83.5) | 77.0(71.0,84.0) | 175.16 | <0.001 |
| 年龄段 | 合计 | 男 | 女 | ||
|---|---|---|---|---|---|
| 人数 | 患病率[例(%)] | 人数 | 患病率[例(%)] | ||
| 35~39岁 | 1 623 | 470 | 30(6.4) | 1 153 | 23(2.0) |
| 40~49岁 | 8 329 | 2 679 | 260(9.7) | 5 650 | 354(6.3)a |
| 50~59岁 | 11 990 | 4 193 | 647(15.4)ab | 7 797 | 1 183(15.2)ab |
| 60~69岁 | 14 478 | 6 778 | 1 175(17.3)ab | 7 700 | 1 861(24.2)abc |
| 70~75岁 | 6 017 | 3 167 | 629(19.9)abc | 2 850 | 828(29.1)abcd |
| 合计 | 42 437 | 17 287 | 2 741(15.9) | 25 150 | 4 249(16.9) |
Table 4 Prevalence of CMM in different genders and age groups
| 年龄段 | 合计 | 男 | 女 | ||
|---|---|---|---|---|---|
| 人数 | 患病率[例(%)] | 人数 | 患病率[例(%)] | ||
| 35~39岁 | 1 623 | 470 | 30(6.4) | 1 153 | 23(2.0) |
| 40~49岁 | 8 329 | 2 679 | 260(9.7) | 5 650 | 354(6.3)a |
| 50~59岁 | 11 990 | 4 193 | 647(15.4)ab | 7 797 | 1 183(15.2)ab |
| 60~69岁 | 14 478 | 6 778 | 1 175(17.3)ab | 7 700 | 1 861(24.2)abc |
| 70~75岁 | 6 017 | 3 167 | 629(19.9)abc | 2 850 | 828(29.1)abcd |
| 合计 | 42 437 | 17 287 | 2 741(15.9) | 25 150 | 4 249(16.9) |
| 自变量 | 男 | 女 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 模型1 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.757(1.531~2.017) | <0.001 | 1.584(1.417~1.771) | <0.001 |
| M3/F3 | 2.274(1.990~2.598) | <0.001 | 2.253(2.025~2.507) | <0.001 |
| M4/F4 | 3.364(2.958~3.825) | <0.001 | 3.399(3.067~3.767) | <0.001 |
| 模型2 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.743(1.518~2.001) | <0.001 | 1.430(1.277~1.602) | <0.001 |
| M3/F3 | 2.231(1.952~2.550) | <0.001 | 1.784(1.599~1.991) | <0.001 |
| M4/F4 | 3.170(2.786~3.607) | <0.001 | 2.221(1.995~2.472) | <0.001 |
| 模型3 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.719(1.497~1.975) | <0.001 | 1.444(1.289~1.618) | <0.001 |
| M3/F3 | 2.195(1.919~2.510) | <0.001 | 1.809(1.621~2.019) | <0.001 |
| M4/F4 | 3.128(2.748~3.561) | <0.001 | 2.264(2.033~2.521) | <0.001 |
Table 5 Multivariate Logistic regression analysis of the effect of BRI on CMM in normal body weight populations of different sexes
| 自变量 | 男 | 女 | ||
|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 模型1 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.757(1.531~2.017) | <0.001 | 1.584(1.417~1.771) | <0.001 |
| M3/F3 | 2.274(1.990~2.598) | <0.001 | 2.253(2.025~2.507) | <0.001 |
| M4/F4 | 3.364(2.958~3.825) | <0.001 | 3.399(3.067~3.767) | <0.001 |
| 模型2 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.743(1.518~2.001) | <0.001 | 1.430(1.277~1.602) | <0.001 |
| M3/F3 | 2.231(1.952~2.550) | <0.001 | 1.784(1.599~1.991) | <0.001 |
| M4/F4 | 3.170(2.786~3.607) | <0.001 | 2.221(1.995~2.472) | <0.001 |
| 模型3 | ||||
| BRI(以M1/F1为参照) | ||||
| M2/F2 | 1.719(1.497~1.975) | <0.001 | 1.444(1.289~1.618) | <0.001 |
| M3/F3 | 2.195(1.919~2.510) | <0.001 | 1.809(1.621~2.019) | <0.001 |
| M4/F4 | 3.128(2.748~3.561) | <0.001 | 2.264(2.033~2.521) | <0.001 |
| 中介因子 | 调整协变量后的OR(95%CI) | 介导比例(%) | ||
|---|---|---|---|---|
| 总效应 | 直接效应 | 间接效应 | ||
| TyG指数 | 0.006(0.056~0.070) | 0.028(0.023~0.030) | 0.033(0.031~0.040) | 54.62(50.19~60.00) |
| RC | 0.006(0.056~0.070) | 0.047(0.042~0.050) | 0.014(0.013~0.020) | 22.98(20.70~26.00) |
| 收缩压 | 0.006(0.056~0.070) | 0.046(0.041~0.050) | 0.015(0.014~0.020) | 24.05(22.05~27.00) |
Table 6 Mediator analysis of the association between BRI index and CMM disease
| 中介因子 | 调整协变量后的OR(95%CI) | 介导比例(%) | ||
|---|---|---|---|---|
| 总效应 | 直接效应 | 间接效应 | ||
| TyG指数 | 0.006(0.056~0.070) | 0.028(0.023~0.030) | 0.033(0.031~0.040) | 54.62(50.19~60.00) |
| RC | 0.006(0.056~0.070) | 0.047(0.042~0.050) | 0.014(0.013~0.020) | 22.98(20.70~26.00) |
| 收缩压 | 0.006(0.056~0.070) | 0.046(0.041~0.050) | 0.015(0.014~0.020) | 24.05(22.05~27.00) |
| [28] |
杨慕坤,贾潇湘,任正洪,等. 绝经还是年龄增长的影响:项针对中年女性冠心病高危因素的前瞻性队列研究[J]. 中国全科医学,2024,27(3):280-285.
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
潘姚佳,王为强,易伟卓,等. 不同性别中年肥胖居民三酰甘油葡萄糖乘积指数与心血管疾病高危风险的关系研究[J]. 中国全科医学,2023,26(29):3628-3635.
|
| [38] |
|
| [39] |
何建建,李海婧,王彬,等.三酰甘油-葡萄糖指数评估急性冠状动脉综合征合并糖尿病患者冠状动脉病变程度和远期不良心血管事件的价值[J].河北医科大学学报,2025,46(1):14-19.
|
| [1] |
|
| [2] |
|
| [3] |
Association of cardiometabolic multimorbidity with mortality[J]. JAMA,2015,314(1):52-60. DOI:10.1001/jama.2015.7008.
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志,2024,32(7):603-700. DOI:10.16439/j.issn.1673-7245.2024.07.002.
|
| [12] |
《中国老年2型糖尿病防治临床指南》编写组. 中国老年2型糖尿病防治临床指南(2022年版)[J]. 中国糖尿病杂志,2022,30(1):2-51.
|
| [13] |
国家心血管病中心,中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志,2024,39(7):625-660.
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
傅方琳,潘姚佳,韩正,等. 不同性别老年人群身体圆度指数与体质量正常代谢异常表型的相关性研究:以三酰甘油葡萄糖乘积指数为潜在影响因素[J]. 中国全科医学,2024,27(30):3746-3752,3757.
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
韩正,王为强,潘姚佳,等. 35岁以上人群连续代谢综合征评分及其他肥胖指标与心脏代谢性共病关系:基于安徽省的横断面研究[J]. 中国全科医学,2024,27(27):3344-3350,3358.
|
| [27] |
王静,李虎,顾菲,等. 内脏脂肪面积对体质指数正常内脏脂肪面积超标体检人群缺血性心血管病十年发病风险的评估价值研究[J]. 中国全科医学,2019,22(3):279-283.
|
| [1] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [2] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [3] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [4] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [5] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [6] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [7] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [8] | LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409. |
| [9] | Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139. |
| [10] | LI Jiali, LIU Fan, KE Lixin, LI Huijuan, WANG Haibo, ZHAO Xiaoxiao, ZHAO Xinke, LU Cuncun. Disease Burden of Obesity among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(15): 2067-2076. |
| [11] | CHEN Xiaolong, JIN Jing, HUA Jialu, LI Yuyu, PAN Youjia, PAN Qi, TU Chunjing, WANG Ping. Study on the Optimal Time-use Composition of 24-hour Movement Behaviors for Obesity Prevention in College Students [J]. Chinese General Practice, 2026, 29(12): 1525-1532. |
| [12] | YANG Lei, GUAN Hua. Application Progress of Generative Artificial Intelligence in Weight Management [J]. Chinese General Practice, 2026, 29(12): 1533-1540. |
| [13] | YAN Manli, ZHANG Baoqing, HUANG Lei, LI Xiang. A New Chapter in Obesity Treatment: Mechanisms and Clinical Research Progress of Multi-target Peptide Agonists [J]. Chinese General Practice, 2026, 29(12): 1511-1519. |
| [14] | HE Zhiguang, QIU Shanjiao, CHEN Zhang, LI Anchun, HUANG Wenjing. Interpretation and Discussion of the RACGP Guidelines for Preventive Activities in General Practice: Screening for Weight Issues and Preventive Strategies [J]. Chinese General Practice, 2026, 29(12): 1505-1510. |
| [15] | GU Handong, LU Hongrun, GU Keyi, HAN Zheng, YANG Fei, FU Xiaoya, WANG Weiqiang. Association Research between Relative Fat Mass and the Incidence Risk of Cardiometabolic Multimorbidity [J]. Chinese General Practice, 2026, 29(11): 1456-1462. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||